tiprankstipranks
Advertisement
Advertisement

ANL Stock Latest News

Adlai Nortye Redomiciles to Singapore and Updates Nasdaq Identity
Company AnnouncementsAdlai Nortye Redomiciles to Singapore and Updates Nasdaq Identity
5d ago
6K
ANL
Adlai Nortye Boosts Cash Reserves and Advances RAS-Focused Oncology Pipeline in First Half of 2026
PremiumCompany Announcements
Adlai Nortye Boosts Cash Reserves and Advances RAS-Focused Oncology Pipeline in First Half of 2026
10d ago
6K
ANL
Adlai Nortye Initiated at Buy as First-in-Class RASiCA ADC Enters Clinic; $20 Price Target Reiterated
PremiumRatings
Adlai Nortye Initiated at Buy as First-in-Class RASiCA ADC Enters Clinic; $20 Price Target Reiterated
21d ago
ANL
Adlai Nortye Wins Australian Clearance to Launch First-in-Class Pan-RAS(ON) ADC Trial
PremiumCompany Announcements
Adlai Nortye Wins Australian Clearance to Launch First-in-Class Pan-RAS(ON) ADC Trial
21d ago
6K
ANL
Adlai Nortye submits clinical trial notification to Australia TGA for AN4035
PremiumThe Fly
Adlai Nortye submits clinical trial notification to Australia TGA for AN4035
21d ago
ANL
Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway
PremiumRatingsAdlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway
28d ago
ANL
Adlai Nortye Begins Weekly Dosing Arm in Global Phase 1 Trial of RAS Inhibitor AN9025
Premium
Company Announcements
Adlai Nortye Begins Weekly Dosing Arm in Global Phase 1 Trial of RAS Inhibitor AN9025
1M ago
6K
ANL
Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target Maintained
Premium
Ratings
Adlai Nortye: Buy Rating Reaffirmed as Dual-Arm AN9025 Strategy Advances; $20 Price Target Maintained
1M ago
ANL
Adlai Nortye doses first patient in AN9025 trial
PremiumThe Fly
Adlai Nortye doses first patient in AN9025 trial
1M ago
ANL
Cantor starts Adlai Nortye at Overweight, sees 180% upside
PremiumThe Fly
Cantor starts Adlai Nortye at Overweight, sees 180% upside
2M ago
ANL
Adlai Nortye initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Adlai Nortye initiated with an Overweight at Cantor Fitzgerald
2M ago
ANL
Adlai Nortye initiated with an Outperform at Oppenheimer
PremiumThe Fly
Adlai Nortye initiated with an Outperform at Oppenheimer
3M ago
ANL
Adlai Nortye initiated with a Buy at JonesResearch
PremiumThe FlyAdlai Nortye initiated with a Buy at JonesResearch
3M ago
ANL
ERAS
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright
Premium
The Fly
Adlai Nortye price target raised to $20 from $16 at H.C. Wainwright
4M ago
ANL
Adlai Nortye Raises $150 Million in Oversubscribed Private Placement to Advance Cancer Pipeline
Premium
Company Announcements
Adlai Nortye Raises $150 Million in Oversubscribed Private Placement to Advance Cancer Pipeline
4M ago
6K
ANL
Adlai Nortye Ltd (ADR) trading resumes
PremiumThe Fly
Adlai Nortye Ltd (ADR) trading resumes
4M ago
ANL
Adlai Nortye Ltd (ADR) trading halted, volatility trading pause
PremiumThe Fly
Adlai Nortye Ltd (ADR) trading halted, volatility trading pause
4M ago
ANL
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up
PremiumCompany Announcements
Adlai Nortye Reshapes Top Leadership as President Retires and R&D Chief Steps Up
5M ago
6K
ANL
Leerink bullish on Adlai Nortye, initiates with an Outperform
PremiumThe Fly
Leerink bullish on Adlai Nortye, initiates with an Outperform
5M ago
ANL
Adlai Nortye initiated with an Outperform at Leerink
PremiumThe FlyAdlai Nortye initiated with an Outperform at Leerink
5M ago
ANL
Adlai Nortye files to sell $600M of Class A ordinary shares
Premium
The Fly
Adlai Nortye files to sell $600M of Class A ordinary shares
6M ago
ANL
Adlai Nortye files to sell 64.62M Class A ordinary shares for holders
Premium
The Fly
Adlai Nortye files to sell 64.62M Class A ordinary shares for holders
6M ago
ANL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >